| 383 Rabs and the exocyst in ciliogenesis, tubulogenesis and beyond 387 Autophagy and apoptosis: what is the connection? AJ MacQueen, A Hochwagen, P Laprise, U Tepass, P Ji, M Murata-Hori, ... | | |
| A data mining framework for predicting drug response in cancer K Vougas, T Sakelaropoulos, F Koinis, A Polyzos, A Kotsinas, ... | | |
| A deep learning framework for predicting response to therapy in cancer T Sakellaropoulos, K Vougas, S Narang, F Koinis, A Kotsinas, A Polyzos, ... Cell reports 29 (11), 3367-3373. e4, 2019 | 184 | 2019 |
| A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma E Jonasch, E Hasanov, PG Corn, T Moss, KR Shaw, S Stovall, V Marcott, ... Annals of Oncology 28 (4), 804-808, 2017 | 40 | 2017 |
| A structure-function characterization of the ER membrane protein atlastin TJ Moss Rice University, 2012 | | 2012 |
| A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease T Nishikawa, N Bellance, A Damm, H Bing, Z Zhu, K Handa, MI Yovchev, ... Journal of hepatology 60 (6), 1203-1211, 2014 | 141 | 2014 |
| Abstract A096: Phase II study of the PARP inhibitor talazoparib in advanced cancer patients with somatic alterations in BRCA1/2, mutations/deletions in PTEN or PTEN loss, aberrations … SA Piha-Paul, WW Xiong, T Moss, RM Mostorino, S Sedelmeier, K Hess, ... Molecular Cancer Therapeutics 17 (1_Supplement), A096-A096, 2018 | 4 | 2018 |
| Baseline cfDNA characteristics and evolution of cfDNA profile during treatment with selective FGFR inhibitor TAS-120. TJ Moss, J Rodon Ahnert, HD Oakley, M Kahle, DD Karp, S Pant, J Jacob, ... Journal of Clinical Oncology 37 (15_suppl), 3056-3056, 2019 | 9 | 2019 |
| Comprehensive genomic characterization of upper tract urothelial carcinoma TJ Moss, Y Qi, L Xi, B Peng, TB Kim, NE Ezzedine, ME Mosqueda, ... European urology 72 (4), 641-649, 2017 | 201 | 2017 |
| Comprehensive genomic characterization of upper tract urothelial carcinoma (UTUC). TJ Moss, Y Qi, L Xi, B Peng, ME Mosqueda, C Guo, M Ittman, DA Wheeler, ... Journal of Clinical Oncology 35 (6_suppl), 375-375, 2017 | 1 | 2017 |
| Computational Approaches for Visualization and Integration of Omics Data V Sehgal, TJ Moss, PT Ram Comprehensive Analytical Chemistry 63, 443-454, 2014 | | 2014 |
| Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in cholangiocarcinoma with FGFR fusions/rearrangements TIP DiPeri, M Zhao, T Moss, M Kahle, P Rauli, SS Lee, A Halim, H Hirai, ... Cancer Research 82 (12_Supplement), 2618-2618, 2022 | 1 | 2022 |
| Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma TP DiPeri, M Zhao, KW Evans, K Varadarajan, T Moss, S Scott, MP Kahle, ... Journal of Hepatology 80 (2), 322-334, 2024 | 2 | 2024 |
| Copy number gain of hsa-miR-569 at 3q26. 2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers P Chaluvally-Raghavan, F Zhang, S Pradeep, MP Hamilton, X Zhao, ... Cancer Cell 26 (6), 863-879, 2014 | 53 | 2014 |
| Cupid: simultaneous reconstruction of microRNA-target and ceRNA networks HS Chiu, D Llobet-Navas, X Yang, WJ Chung, A Ambesi-Impiombato, ... Genome research 25 (2), 257-267, 2015 | 107 | 2015 |
| Design of phenotype-driven flux analysis approach for personalized metabolic models of cancer patients A Achreja, L Yang, T Moss, V Sehgal, J Marini, PT Ram, D Nagrath Cancer Research 75 (15_Supplement), 1204-1204, 2015 | | 2015 |
| Direct upregulation of STAT3 by MicroRNA-551b-3p deregulates growth and metastasis of ovarian cancer P Chaluvally-Raghavan, KJ Jeong, S Pradeep, AM Silva, S Yu, W Liu, ... Cell reports 15 (7), 1493-1504, 2016 | 89 | 2016 |
| Erratum: Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer EG Seviour, V Sehgal, Y Lu, Z Luo, T Moss, F Zhang, SM Hill, W Liu, ... Oncogene 35 (6), 801, 2016 | 11 | 2016 |
| Erratum: Homotypic fusion of ER membranes requires the dynamin-like GTPase Atlastin G Orso, D Pendin, S Liu, J Tosetto, TJ Moss, JE Faust, M Micaroni, ... Nature 464 (7290), 942-942, 2010 | | 2010 |
| Expression analysis of same-patient metachronous and synchronous upper tract and bladder urothelial carcinoma FG Petros, W Choi, Y Qi, T Moss, R Li, X Su, CC Guo, B Czerniak, ... The Journal of urology 206 (3), 548-557, 2021 | 11 | 2021 |
James McNewRice University在 rice.edu 的电子邮件经过验证
